皮膚科医薬品のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Dermatological Medicine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16125 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

皮膚科医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の皮膚科医薬品の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の皮膚科医薬品の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 皮膚科医薬品市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・抗感染薬、コルチコステロイド、抗ニキビ、カルシニューリン阻害剤、レチノイド、その他 用途別セグメントは次のように区分されます。 ・脱毛症、ヘルペス、乾癬、酒皶、アトピー性皮膚炎、その他 世界の皮膚科医薬品市場の主要な市場プレーヤーは以下のとおりです。 ・Johnson and Johnson、GSK、Pfizer、AbbVie、Bayer、Merck、Reckitt Benckiser、Taisho Pharmaceutical、Perrigo、Ikeda Mohando、DermaPharm A/S、LEO Pharma、China Resources Pharmaceutical Group、Chongqing Huapont Pharm Co.、Bright Future Pharmaceutical、Xiuzheng Pharmaceutical Group、China National Pharmaceutical Group、Harbin Letai、Hebei Xinglong Xili Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、皮膚科医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な皮膚科医薬品メーカーの企業概要、2019年～2021年までの皮膚科医薬品の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な皮膚科医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別皮膚科医薬品の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの皮膚科医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での皮膚科医薬品市場予測を収録しています。 ・第12、13、14章では、皮膚科医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Johnson and Johnson、GSK、Pfizer、AbbVie、Bayer、Merck、Reckitt Benckiser、Taisho Pharmaceutical、Perrigo、Ikeda Mohando、DermaPharm A/S、LEO Pharma、China Resources Pharmaceutical Group、Chongqing Huapont Pharm Co.、Bright Future Pharmaceutical、Xiuzheng Pharmaceutical Group、China National Pharmaceutical Group、Harbin Letai、Hebei Xinglong Xili Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：抗感染薬、コルチコステロイド、抗ニキビ、カルシニューリン阻害剤、レチノイド、その他 ・用途別分析2016年-2026年：脱毛症、ヘルペス、乾癬、酒皶、アトピー性皮膚炎、その他 ・皮膚科医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・皮膚科医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・皮膚科医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・皮膚科医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・皮膚科医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Dermatological Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Dermatological Medicine size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Dermatological Medicine market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Dermatological Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Anti-infectives
Corticosteroids
Anti-acne
Calcineurin Inhibitors
Retinoids
Others

Market segment by Application can be divided into
Alopecia
Herpes
Psoriasis
Rosacea
Atopic Dermatitis
Others

The key market players for global Dermatological Medicine market are listed below:
Johnson and Johnson
GSK
Pfizer
AbbVie
Bayer
Merck
Reckitt Benckiser
Taisho Pharmaceutical
Perrigo
Ikeda Mohando
DermaPharm A/S
LEO Pharma
China Resources Pharmaceutical Group
Chongqing Huapont Pharm Co.
Bright Future Pharmaceutical
Xiuzheng Pharmaceutical Group
China National Pharmaceutical Group
Harbin Letai
Hebei Xinglong Xili Pharmaceutical

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Dermatological Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatological Medicine, with price, sales, revenue and global market share of Dermatological Medicine from 2019 to 2021.
Chapter 3, the Dermatological Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatological Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Dermatological Medicine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Dermatological Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Dermatological Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatological Medicine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Anti-infectives
1.2.3 Corticosteroids
1.2.4 Anti-acne
1.2.5 Calcineurin Inhibitors
1.2.6 Retinoids
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatological Medicine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Alopecia
1.3.3 Herpes
1.3.4 Psoriasis
1.3.5 Rosacea
1.3.6 Atopic Dermatitis
1.3.7 Others
1.4 Global Dermatological Medicine Market Size & Forecast
1.4.1 Global Dermatological Medicine Sales in Value (2016-2026))
1.4.2 Global Dermatological Medicine Sales in Volume (2016-2026)
1.4.3 Global Dermatological Medicine Price by Type (2016-2026) & (US$/Unit)
1.5 Global Dermatological Medicine Production Capacity Analysis
1.5.1 Global Dermatological Medicine Total Production Capacity (2016-2026)
1.5.2 Global Dermatological Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dermatological Medicine Market Drivers
1.6.2 Dermatological Medicine Market Restraints
1.6.3 Dermatological Medicine Trends Analysis
2 Manufacturers Profiles
2.1 Johnson and Johnson
2.1.1 Johnson and Johnson Details
2.1.2 Johnson and Johnson Major Business
2.1.3 Johnson and Johnson Dermatological Medicine Product and Services
2.1.4 Johnson and Johnson Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Dermatological Medicine Product and Services
2.2.4 GSK Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Dermatological Medicine Product and Services
2.3.4 Pfizer Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Dermatological Medicine Product and Services
2.4.4 AbbVie Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Dermatological Medicine Product and Services
2.5.4 Bayer Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Dermatological Medicine Product and Services
2.6.4 Merck Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Reckitt Benckiser
2.7.1 Reckitt Benckiser Details
2.7.2 Reckitt Benckiser Major Business
2.7.3 Reckitt Benckiser Dermatological Medicine Product and Services
2.7.4 Reckitt Benckiser Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Taisho Pharmaceutical
2.8.1 Taisho Pharmaceutical Details
2.8.2 Taisho Pharmaceutical Major Business
2.8.3 Taisho Pharmaceutical Dermatological Medicine Product and Services
2.8.4 Taisho Pharmaceutical Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Perrigo
2.9.1 Perrigo Details
2.9.2 Perrigo Major Business
2.9.3 Perrigo Dermatological Medicine Product and Services
2.9.4 Perrigo Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Ikeda Mohando
2.10.1 Ikeda Mohando Details
2.10.2 Ikeda Mohando Major Business
2.10.3 Ikeda Mohando Dermatological Medicine Product and Services
2.10.4 Ikeda Mohando Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 DermaPharm A/S
2.11.1 DermaPharm A/S Details
2.11.2 DermaPharm A/S Major Business
2.11.3 DermaPharm A/S Dermatological Medicine Product and Services
2.11.4 DermaPharm A/S Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 LEO Pharma
2.12.1 LEO Pharma Details
2.12.2 LEO Pharma Major Business
2.12.3 LEO Pharma Dermatological Medicine Product and Services
2.12.4 LEO Pharma Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 China Resources Pharmaceutical Group
2.13.1 China Resources Pharmaceutical Group Details
2.13.2 China Resources Pharmaceutical Group Major Business
2.13.3 China Resources Pharmaceutical Group Dermatological Medicine Product and Services
2.13.4 China Resources Pharmaceutical Group Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Chongqing Huapont Pharm Co.
2.14.1 Chongqing Huapont Pharm Co. Details
2.14.2 Chongqing Huapont Pharm Co. Major Business
2.14.3 Chongqing Huapont Pharm Co. Dermatological Medicine Product and Services
2.14.4 Chongqing Huapont Pharm Co. Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Bright Future Pharmaceutical
2.15.1 Bright Future Pharmaceutical Details
2.15.2 Bright Future Pharmaceutical Major Business
2.15.3 Bright Future Pharmaceutical Dermatological Medicine Product and Services
2.15.4 Bright Future Pharmaceutical Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Xiuzheng Pharmaceutical Group
2.16.1 Xiuzheng Pharmaceutical Group Details
2.16.2 Xiuzheng Pharmaceutical Group Major Business
2.16.3 Xiuzheng Pharmaceutical Group Dermatological Medicine Product and Services
2.16.4 Xiuzheng Pharmaceutical Group Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 China National Pharmaceutical Group
2.17.1 China National Pharmaceutical Group Details
2.17.2 China National Pharmaceutical Group Major Business
2.17.3 China National Pharmaceutical Group Dermatological Medicine Product and Services
2.17.4 China National Pharmaceutical Group Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Harbin Letai
2.18.1 Harbin Letai Details
2.18.2 Harbin Letai Major Business
2.18.3 Harbin Letai Dermatological Medicine Product and Services
2.18.4 Harbin Letai Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Hebei Xinglong Xili Pharmaceutical
2.19.1 Hebei Xinglong Xili Pharmaceutical Details
2.19.2 Hebei Xinglong Xili Pharmaceutical Major Business
2.19.3 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product and Services
2.19.4 Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Dermatological Medicine Sales by Manufacturer
3.1 Global Dermatological Medicine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Dermatological Medicine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Dermatological Medicine
3.4 Market Concentration Rate
3.4.1 Top 3 Dermatological Medicine Manufacturer Market Share
3.4.2 Top 6 Dermatological Medicine Manufacturer Market Share
3.5 Global Dermatological Medicine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Dermatological Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dermatological Medicine Market Size by Region
4.1.1 Global Dermatological Medicine Sales in Volume by Region (2016-2026)
4.1.2 Global Dermatological Medicine Revenue by Region (2016-2026)
4.2 North America Dermatological Medicine Revenue (2016-2026)
4.3 Europe Dermatological Medicine Revenue (2016-2026)
4.4 Asia-Pacific Dermatological Medicine Revenue (2016-2026)
4.5 South America Dermatological Medicine Revenue (2016-2026)
4.6 Middle East and Africa Dermatological Medicine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Dermatological Medicine Sales in Volume by Type (2016-2026)
5.2 Global Dermatological Medicine Revenue by Type (2016-2026)
5.3 Global Dermatological Medicine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Dermatological Medicine Sales in Volume by Application (2016-2026)
6.2 Global Dermatological Medicine Revenue by Application (2016-2026)
6.3 Global Dermatological Medicine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Dermatological Medicine Sales by Type (2016-2026)
7.2 North America Dermatological Medicine Sales by Application (2016-2026)
7.3 North America Dermatological Medicine Market Size by Country
7.3.1 North America Dermatological Medicine Sales in Volume by Country (2016-2026)
7.3.2 North America Dermatological Medicine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Dermatological Medicine Sales by Type (2016-2026)
8.2 Europe Dermatological Medicine Sales by Application (2016-2026)
8.3 Europe Dermatological Medicine Market Size by Country
8.3.1 Europe Dermatological Medicine Sales in Volume by Country (2016-2026)
8.3.2 Europe Dermatological Medicine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Dermatological Medicine Sales by Type (2016-2026)
9.2 Asia-Pacific Dermatological Medicine Sales by Application (2016-2026)
9.3 Asia-Pacific Dermatological Medicine Market Size by Region
9.3.1 Asia-Pacific Dermatological Medicine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Dermatological Medicine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Dermatological Medicine Sales by Type (2016-2026)
10.2 South America Dermatological Medicine Sales by Application (2016-2026)
10.3 South America Dermatological Medicine Market Size by Country
10.3.1 South America Dermatological Medicine Sales in Volume by Country (2016-2026)
10.3.2 South America Dermatological Medicine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dermatological Medicine Sales by Type (2016-2026)
11.2 Middle East & Africa Dermatological Medicine Sales by Application (2016-2026)
11.3 Middle East & Africa Dermatological Medicine Market Size by Country
11.3.1 Middle East & Africa Dermatological Medicine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Dermatological Medicine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Dermatological Medicine Typical Distributors
12.3 Dermatological Medicine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Dermatological Medicine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Dermatological Medicine Revenue by Application, (USD Million), 2021-2026
Table 3. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson and Johnson Major Business
Table 5. Johnson and Johnson Dermatological Medicine Product and Services
Table 6. Johnson and Johnson Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Dermatological Medicine Product and Services
Table 10. GSK Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Dermatological Medicine Product and Services
Table 14. Pfizer Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. AbbVie Basic Information, Manufacturing Base and Competitors
Table 16. AbbVie Major Business
Table 17. AbbVie Dermatological Medicine Product and Services
Table 18. AbbVie Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Dermatological Medicine Product and Services
Table 22. Bayer Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Dermatological Medicine Product and Services
Table 26. Merck Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Reckitt Benckiser Basic Information, Manufacturing Base and Competitors
Table 28. Reckitt Benckiser Major Business
Table 29. Reckitt Benckiser Dermatological Medicine Product and Services
Table 30. Reckitt Benckiser Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Taisho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Taisho Pharmaceutical Major Business
Table 33. Taisho Pharmaceutical Dermatological Medicine Product and Services
Table 34. Taisho Pharmaceutical Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Perrigo Basic Information, Manufacturing Base and Competitors
Table 36. Perrigo Major Business
Table 37. Perrigo Dermatological Medicine Product and Services
Table 38. Perrigo Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Ikeda Mohando Basic Information, Manufacturing Base and Competitors
Table 40. Ikeda Mohando Major Business
Table 41. Ikeda Mohando Dermatological Medicine Product and Services
Table 42. Ikeda Mohando Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. DermaPharm A/S Basic Information, Manufacturing Base and Competitors
Table 44. DermaPharm A/S Major Business
Table 45. DermaPharm A/S Dermatological Medicine Product and Services
Table 46. DermaPharm A/S Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 48. LEO Pharma Major Business
Table 49. LEO Pharma Dermatological Medicine Product and Services
Table 50. LEO Pharma Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. China Resources Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 52. China Resources Pharmaceutical Group Major Business
Table 53. China Resources Pharmaceutical Group Dermatological Medicine Product and Services
Table 54. China Resources Pharmaceutical Group Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Chongqing Huapont Pharm Co. Basic Information, Manufacturing Base and Competitors
Table 56. Chongqing Huapont Pharm Co. Major Business
Table 57. Chongqing Huapont Pharm Co. Dermatological Medicine Product and Services
Table 58. Chongqing Huapont Pharm Co. Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Bright Future Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Bright Future Pharmaceutical Major Business
Table 61. Bright Future Pharmaceutical Dermatological Medicine Product and Services
Table 62. Bright Future Pharmaceutical Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Xiuzheng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 64. Xiuzheng Pharmaceutical Group Major Business
Table 65. Xiuzheng Pharmaceutical Group Dermatological Medicine Product and Services
Table 66. Xiuzheng Pharmaceutical Group Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. China National Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 68. China National Pharmaceutical Group Major Business
Table 69. China National Pharmaceutical Group Dermatological Medicine Product and Services
Table 70. China National Pharmaceutical Group Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Harbin Letai Basic Information, Manufacturing Base and Competitors
Table 72. Harbin Letai Major Business
Table 73. Harbin Letai Dermatological Medicine Product and Services
Table 74. Harbin Letai Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Hebei Xinglong Xili Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Hebei Xinglong Xili Pharmaceutical Major Business
Table 77. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Product and Services
Table 78. Hebei Xinglong Xili Pharmaceutical Dermatological Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Global Dermatological Medicine Sales by Manufacturer (2019-2021e) & (K Units)
Table 80. Global Dermatological Medicine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 81. Market Position of Manufacturers in Dermatological Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 82. Global Dermatological Medicine Production Capacity by Company, (K Units): 2020 VS 2021
Table 83. Head Office and Dermatological Medicine Production Site of Key Manufacturer
Table 84. Dermatological Medicine New Entrant and Capacity Expansion Plans
Table 85. Dermatological Medicine Mergers & Acquisitions in the Past Five Years
Table 86. Global Dermatological Medicine Sales by Region (2016-2021e) & (K Units)
Table 87. Global Dermatological Medicine Sales by Region (2021-2026) & (K Units)
Table 88. Global Dermatological Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 89. Global Dermatological Medicine Revenue by Region (2021-2026) & (USD Million)
Table 90. Global Dermatological Medicine Sales by Type (2016-2021e) & (K Units)
Table 91. Global Dermatological Medicine Sales by Type (2021-2026) & (K Units)
Table 92. Global Dermatological Medicine Revenue by Type (2016-2021e) & (USD Million)
Table 93. Global Dermatological Medicine Revenue by Type (2021-2026) & (USD Million)
Table 94. Global Dermatological Medicine Price by Type (2016-2021e) & (US$/Unit)
Table 95. Global Dermatological Medicine Price by Type (2021-2026) & (US$/Unit)
Table 96. Global Dermatological Medicine Sales by Application (2016-2021e) & (K Units)
Table 97. Global Dermatological Medicine Sales by Application (2021-2026) & (K Units)
Table 98. Global Dermatological Medicine Revenue by Application (2016-2021e) & (USD Million)
Table 99. Global Dermatological Medicine Revenue by Application (2021-2026) & (USD Million)
Table 100. Global Dermatological Medicine Price by Application (2016-2021e) & (US$/Unit)
Table 101. Global Dermatological Medicine Price by Application (2021-2026) & (US$/Unit)
Table 102. North America Dermatological Medicine Sales by Country (2016-2021e) & (K Units)
Table 103. North America Dermatological Medicine Sales by Country (2021-2026) & (K Units)
Table 104. North America Dermatological Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 105. North America Dermatological Medicine Revenue by Country (2021-2026) & (USD Million)
Table 106. North America Dermatological Medicine Sales by Type (2016-2021e) & (K Units)
Table 107. North America Dermatological Medicine Sales by Type (2021-2026) & (K Units)
Table 108. North America Dermatological Medicine Sales by Application (2016-2021e) & (K Units)
Table 109. North America Dermatological Medicine Sales by Application (2021-2026) & (K Units)
Table 110. Europe Dermatological Medicine Sales by Country (2016-2021e) & (K Units)
Table 111. Europe Dermatological Medicine Sales by Country (2021-2026) & (K Units)
Table 112. Europe Dermatological Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 113. Europe Dermatological Medicine Revenue by Country (2021-2026) & (USD Million)
Table 114. Europe Dermatological Medicine Sales by Type (2016-2021e) & (K Units)
Table 115. Europe Dermatological Medicine Sales by Type (2021-2026) & (K Units)
Table 116. Europe Dermatological Medicine Sales by Application (2016-2021e) & (K Units)
Table 117. Europe Dermatological Medicine Sales by Application (2021-2026) & (K Units)
Table 118. Asia-Pacific Dermatological Medicine Sales by Region (2016-2021e) & (K Units)
Table 119. Asia-Pacific Dermatological Medicine Sales by Region (2021-2026) & (K Units)
Table 120. Asia-Pacific Dermatological Medicine Revenue by Region (2016-2021e) & (USD Million)
Table 121. Asia-Pacific Dermatological Medicine Revenue by Region (2021-2026) & (USD Million)
Table 122. Asia-Pacific Dermatological Medicine Sales by Type (2016-2021e) & (K Units)
Table 123. Asia-Pacific Dermatological Medicine Sales by Type (2021-2026) & (K Units)
Table 124. Asia-Pacific Dermatological Medicine Sales by Application (2016-2021e) & (K Units)
Table 125. Asia-Pacific Dermatological Medicine Sales by Application (2021-2026) & (K Units)
Table 126. South America Dermatological Medicine Sales by Country (2016-2021e) & (K Units)
Table 127. South America Dermatological Medicine Sales by Country (2021-2026) & (K Units)
Table 128. South America Dermatological Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 129. South America Dermatological Medicine Revenue by Country (2021-2026) & (USD Million)
Table 130. South America Dermatological Medicine Sales by Type (2016-2021e) & (K Units)
Table 131. South America Dermatological Medicine Sales by Type (2021-2026) & (K Units)
Table 132. South America Dermatological Medicine Sales by Application (2016-2021e) & (K Units)
Table 133. South America Dermatological Medicine Sales by Application (2021-2026) & (K Units)
Table 134. Middle East & Africa Dermatological Medicine Sales by Country (2016-2021e) & (K Units)
Table 135. Middle East & Africa Dermatological Medicine Sales by Country (2021-2026) & (K Units)
Table 136. Middle East & Africa Dermatological Medicine Revenue by Country (2016-2021e) & (USD Million)
Table 137. Middle East & Africa Dermatological Medicine Revenue by Country (2021-2026) & (USD Million)
Table 138. Middle East & Africa Dermatological Medicine Sales by Type (2016-2021e) & (K Units)
Table 139. Middle East & Africa Dermatological Medicine Sales by Type (2021-2026) & (K Units)
Table 140. Middle East & Africa Dermatological Medicine Sales by Application (2016-2021e) & (K Units)
Table 141. Middle East & Africa Dermatological Medicine Sales by Application (2021-2026) & (K Units)
Table 142. Direct Channel Pros & Cons
Table 143. Indirect Channel Pros & Cons
Table 144. Dermatological Medicine Typical Distributors
Table 145. Dermatological Medicine Typical Customers
List of Figures
Figure 1. Dermatological Medicine Picture
Figure 2. Global Dermatological Medicine Sales Market Share by Type in 2020
Figure 3. Anti-infectives
Figure 4. Corticosteroids
Figure 5. Anti-acne
Figure 6. Calcineurin Inhibitors
Figure 7. Retinoids
Figure 8. Others
Figure 9. Global Dermatological Medicine Sales Market Share by Application in 2020
Figure 10. Alopecia
Figure 11. Herpes
Figure 12. Psoriasis
Figure 13. Rosacea
Figure 14. Atopic Dermatitis
Figure 15. Others
Figure 16. Global Dermatological Medicine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 17. Global Dermatological Medicine Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. Global Dermatological Medicine Sales (2016-2026) & (K Units)
Figure 19. Global Dermatological Medicine Price by Type (2016-2026) & (US$/Unit)
Figure 20. Global Dermatological Medicine Production Capacity (2016-2026) & (K Units)
Figure 21. Global Dermatological Medicine Production Capacity by Geographic Region: 2020 VS 2021
Figure 22. Dermatological Medicine Market Drivers
Figure 23. Dermatological Medicine Market Restraints
Figure 24. Dermatological Medicine Market Trends
Figure 25. Global Dermatological Medicine Sales Market Share by Manufacturer in 2020
Figure 26. Global Dermatological Medicine Revenue Market Share by Manufacturer in 2020
Figure 27. Dermatological Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. Top 3 Dermatological Medicine Manufacturer (Revenue) Market Share in 2020
Figure 29. Top 6 Dermatological Medicine Manufacturer (Revenue) Market Share in 2020
Figure 30. Global Dermatological Medicine Sales Market Share by Region (2016-2026)
Figure 31. Global Dermatological Medicine Revenue Market Share by Region (2016-2026)
Figure 32. North America Dermatological Medicine Revenue (2016-2026) & (USD Million)
Figure 33. Europe Dermatological Medicine Revenue (2016-2026) & (USD Million)
Figure 34. Asia-Pacific Dermatological Medicine Revenue (2016-2026) & (USD Million)
Figure 35. South America Dermatological Medicine Revenue (2016-2026) & (USD Million)
Figure 36. Middle East & Africa Dermatological Medicine Revenue (2016-2026) & (USD Million)
Figure 37. Global Dermatological Medicine Sales Market Share by Type (2016-2026)
Figure 38. Global Dermatological Medicine Revenue Market Share by Type (2016-2026)
Figure 39. Global Dermatological Medicine Price by Type (2016-2026) & (US$/Unit)
Figure 40. Global Dermatological Medicine Sales Market Share by Application (2016-2026)
Figure 41. Global Dermatological Medicine Revenue Market Share by Application (2016-2026)
Figure 42. Global Dermatological Medicine Price by Application (2016-2026) & (US$/Unit)
Figure 43. North America Dermatological Medicine Sales Market Share by Type (2016-2026)
Figure 44. North America Dermatological Medicine Sales Market Share by Application (2016-2026)
Figure 45. North America Dermatological Medicine Sales Market Share by Country (2016-2026)
Figure 46. North America Dermatological Medicine Revenue Market Share by Country (2016-2026)
Figure 47. United States Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Dermatological Medicine Sales Market Share by Type (2016-2026)
Figure 51. Europe Dermatological Medicine Sales Market Share by Application (2016-2026)
Figure 52. Europe Dermatological Medicine Sales Market Share by Country (2016-2026)
Figure 53. Europe Dermatological Medicine Revenue Market Share by Country (2016-2026)
Figure 54. Germany Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Dermatological Medicine Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Dermatological Medicine Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Dermatological Medicine Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Dermatological Medicine Revenue Market Share by Region (2016-2026)
Figure 63. China Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Korea Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Dermatological Medicine Sales Market Share by Type (2016-2026)
Figure 70. South America Dermatological Medicine Sales Market Share by Application (2016-2026)
Figure 71. South America Dermatological Medicine Sales Market Share by Country (2016-2026)
Figure 72. South America Dermatological Medicine Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East & Africa Dermatological Medicine Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Dermatological Medicine Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa Dermatological Medicine Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Dermatological Medicine Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Egypt Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. South Africa Dermatological Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source

---